Merck KgaA Stock Down As Phase III Trials Of Evobrutinib In RMS Fail To Meet Primary Goals
(RTTNews) - Shares of Merck KgaA (MKGAY.PK) were losing more than 14 percent in the early morning trading in Germany after the science and technol...
Stay updated with breaking news from Relapsing Multiple Sclerosis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(RTTNews) - Shares of Merck KgaA (MKGAY.PK) were losing more than 14 percent in the early morning trading in Germany after the science and technol...
(RTTNews) - The major U.S. index futures are currently pointing to a higher open on Wednesday, with stocks likely to move to the upside following ...
European stocks closed higher on Wednesday amid rising optimism several central banks, including the Federal Reserve will consider easing their monetary policy, and even start cutting interest rates sometime early next year.
European stocks closed higher on Wednesday amid rising optimism several central banks, including the Federal Reserve will consider easing their monetary policy, and even start cutting interest rates sometime early next year.
Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof speaks to Thomas Warner at the Proactive London after returning from MSMilan2023, the 9th...